Habenula deep brain stimulation for intractable schizophrenia: a pilot study.

Area of Science:

• Neurosurgery
• Psychiatry
• Neurology

Background:

• Schizophrenia presents significant morbidity and mortality.
• Current treatments like antipsychotics and ECT are ineffective for 10-30% of patients.
• Deep brain stimulation (DBS) is a promising intervention for psychiatric disorders.

Purpose of the Study:

• To explore the utility of habenula (HB) DBS in managing severe, chronic, treatment-resistant schizophrenia.
• To assess the safety and efficacy of HB DBS in a clinical setting.

Main Methods:

• Two young adult males with treatment-resistant schizophrenia underwent HB DBS surgery.
• Clinical symptoms were monitored post-surgery for improvements and adverse effects.

Main Results:

• Both patients showed initial symptom improvement within 6 months post-HB DBS.
• One patient maintained clinical benefits at 12-month follow-up.
• The other patient experienced symptom worsening, requiring hospitalization and study withdrawal.

Conclusions:

• HB DBS may be a safe and effective surgical option for select patients with treatment-resistant schizophrenia.
• Long-term outcomes and patient selection criteria for HB DBS require further investigation.
• Individual patient responses to HB DBS can vary significantly.